Skip to content
Back to blog

ADHD

ADHD at work: studies and myths

Is ADHD a superpower for entrepreneurship? Not proven: hyperactivity was linked to self-employment, but the study did not measure success.

By Dr. Daniela Málaga··13 min read

Many of the people who come to my practice for ADHD don’t come because they can’t find work or because they were fired. They are doing well, sometimes very well. What they describe is something else: that they deliver by staying late, by lists that keep multiplying, by handing everything in at the last minute, and with a tiredness that nobody around them sees. The studies I review here don’t measure that effort; it is what I hear in my practice. And many of them wonder whether they can really have ADHD if their working life, seen from the outside, works.

Studies on ADHD and work answer something more useful than “yes” or “no”. Here is what they show, what they don’t show and what gets repeated without support.

How much does ADHD weigh at work?

The most useful study to answer this is a World Health Organization survey carried out between 2001 and 2003 in ten countries: Belgium, Colombia, France, Germany, Italy, Lebanon, Mexico, the Netherlands, Spain and the United States. It included more than 7000 working people aged 18 to 44. On average, an estimated 3.5% met criteria for ADHD, with considerable variation between countries.

Before using that figure, a few clarifications:

  • It does not come from diagnosing each person. A questionnaire was used and, with clinical interviews carried out only in the United States, the probability of ADHD was calculated for each respondent. The authors warn that they cannot confirm that this calibration works equally well in other countries.
  • It used the diagnostic criteria of the time, which were designed with children in mind, and the authors consider their figures to be on the conservative side.
  • Peru was not in the survey, and in Colombia and Mexico only urban areas were surveyed. It is a reference, not the percentage of Peruvian workers with ADHD.

The US part of that same survey, covering all adults aged 18 to 44 and not only those who were working, estimated 4.4%: it is a different population, so it is not added to or averaged with the previous figure.

What the WHO survey says most is not how many, but how much it costs. On average, ADHD was associated with 22.1 days a year of lost performance, compared with similar workers without ADHD. Those days are not 22 absences: each day the person could not work or carry out their usual activities counted as one lost day, and each day they worked but did less, or with less care, counted as half a day. They were calculated from what each person reported about the last month and scaled up to a year. The figure varied a lot between countries.

And a fact worth looking at: more than half of that loss did not come from missing work, but from days when the person did work or carry out their activities, but felt they were getting less done or doing it with less care. After accounting for anxiety, depression and other disorders that often accompany ADHD, the loss fell to 15.8 days a year, but was still associated with ADHD.

If I’m doing well at work, can I have ADHD?

Yes. And there are reasons why it goes unnoticed.

In the US survey, most adults with ADHD were working: 72%. In the WHO survey, ADHD was in general as frequent among those who worked as among those who did not, although when broken down it was somewhat more frequent among the unemployed (5.5% vs 3.5%). Having a job is not a sign that ADHD isn’t there.

There is an interesting nuance. In the WHO survey, ADHD was less frequent among professionals than among other workers, and the authors suggest this could be because ADHD makes it harder to reach that kind of job. But among those who had ADHD, the authors found no differences between occupations, professionals included, in how strongly it was associated with lower performance. There are no signs that reaching a professional position protects against that cost.

The 2019 European expert consensus on ADHD in adults describes this group well: high-functioning adults may not show the typical pattern of difficulties. They can develop skills that compensate for the more visible problems, and some find jobs that fit the way they function. They can excel in some areas of their lives and still struggle with routine tasks, such as paying bills on time.

What does that look like day to day? A study of 460 adults in the United States, with and without ADHD, found that in adulthood inattention is part of broader difficulties with organizing and managing oneself. Among the symptoms most closely linked to that pattern were not being able to work without a deadline and not finishing tasks on time. That study did not measure job performance, and on their own these difficulties do not indicate ADHD: they are common, and the study could not tell whether they are specific to the disorder.

If you recognize yourself in the constant effort to look as if everything is under control, I wrote about that in ADHD: why hiding it doesn’t just exhaust you, it pushes people away.

Is ADHD a superpower for entrepreneurship?

It is an idea that circulates a lot, almost always accompanied by the list of famous entrepreneurs who supposedly have ADHD. Those lists have a basic problem: we only see the people who did well.

A population study analyzed 7208 adult twins in Sweden, comparing the ADHD symptoms they themselves reported with being self-employed. The authors make clear that they did not study diagnosed ADHD, but symptoms. Hyperactivity was associated with a somewhat higher probability of being self-employed; inattention symptoms were not. The authors repeated the analysis with university students in the Netherlands: hyperactivity was again associated with self-employment, inattention was associated with somewhat less, and ADHD symptoms as a whole were only associated in the Swedish sample. The authors interpret this as a possible upside of hyperactivity.

The most important thing is what the study does not measure. It measures who is self-employed, not who does well: the authors themselves acknowledge that they could not analyze how those businesses performed. And they do not rule out the opposite explanation: in that same study, ADHD symptoms were also associated with being unemployed, and some people might end up working for themselves for lack of alternatives.

I found no studies that measure ADHD specifically in general managers or company directors. A review of 143 studies on how to support adults with ADHD at work also warns that they may have included few people in managerial or professional roles. And almost all the studies in this article are of young adults: up to age 44 in the surveys, and in the Swedish studies, mostly under 30. What is known may not reflect well someone holding a senior position at 50.

None of this means that a person with ADHD cannot start a business or lead successfully. It means there is no proof that ADHD is the cause of that success, and that success does not rule out the difficulties either.

What happens when difficulties pile up?

The other extreme also exists, and it is worth looking at carefully. A study using Sweden’s national registers followed for 5 years 9718 young people aged 19 to 29 who were diagnosed with ADHD for the first time between 2006 and 2011. It did not include those who were already receiving a disability pension when diagnosed or who had already taken ADHD medication. Over those 5 years, in Sweden:

  • 21% received a disability pension, compared with 2% of comparable young people without ADHD;
  • 24% had at least one sick leave of more than 90 days, compared with 7%;
  • 19% went through long-term unemployment, compared with 13%.

Some keys to reading those figures correctly:

  • These are people diagnosed in specialist care, who may have more severe conditions than average.
  • The Swedish “disability pension” includes a temporary benefit for young people, within a generous social insurance system; the authors relate this to the problem showing up there more as pensions than as unemployment. It does not translate as-is to Peru.
  • Other conditions diagnosed alongside ADHD explained about a third of the excess in pensions; those that weighed most were autism, behavioral or emotional disorders with onset in childhood, and intellectual disability. In long sick leave they explained much less, and among them depression and anxiety weighed most.

The study does not compare those who received treatment with those who did not, so it does not say how much of this could have been prevented. What it does make clear is that, in diagnosed young adults, ADHD is not a minor issue.

And so as not to stay only with the hard part: the international consensus of the World Federation of ADHD reminds us that the typical patient with ADHD does not have all these problems, or even most of them, and that many people with ADHD lead satisfying and productive lives, especially if they receive treatment.

Does treatment improve performance at work?

First, what is well established: in adults, some ADHD medications reduce core symptoms in the short term. That is what the most recent analysis of clinical trials in adults, published in 2025, shows; it also found that they did not improve other important outcomes, such as quality of life, and that what happens in the long term is understudied. I explain this in more detail in Does ADHD have a cure? What works in treatment.

What is much less measured is how much of that translates to work.

A review of 143 studies on how to support adults with ADHD found that 60.8% evaluated medications, that none was carried out in a workplace and that only 4 had a work outcome as their main objective: too few to know what works best at work.

A large study using Swedish registers compared, in each person aged 16 to 65 with ADHD, the periods when they were taking medication with the periods when they were not. For sick leave of more than 14 days or disability pensions, most medications showed no clear difference; among those under 30, two were associated with less, and among those 30 or older, none were. The periods on medication were associated with fewer hospitalizations. The authors warn that their data on who was working were imprecise, which may have hidden differences; that each medication tends to be prescribed to different people, which may have influenced the results; and that they had no data on psychotherapy or psychoeducation.

In short: medications reduce symptoms, at least in the short term, and their effect on a person’s career is poorly measured. That is why it is wise to distrust any promise that a pill, on its own, will make you perform better.

The guidelines do not fully agree on the order or on when to combine, but they do agree that treatment has several parts:

  • Understanding your own ADHD. The European consensus recommends psychoeducation, for the person and those close to them, as the first step of treatment, within an approach that combines several tools. Coaching is a common option, but in that review of 143 studies only two evaluated its effectiveness.
  • Changes to the environment. The British NICE guideline (2018, updated in 2019) mentions reducing noise and distractions and organizing work into shorter periods of concentration, with breaks to move around.
  • Medication, when appropriate. NICE recommends offering it to adults whose symptoms continue to cause significant impairment after those changes. It considers it first line because in direct comparison it showed more benefit than non-drug treatment, although the latter also showed benefit, and it reserves combination with therapy for when medication helped but was not enough. At the same time, it acknowledges uncertainty about its long-term benefits and about its adverse effects.
  • Cognitive behavioral therapy for ADHD, as a complement to medication, or as what may be the best option for those who do not want or do not tolerate medication. According to the international consensus, a meta-analysis found moderate improvements in symptoms and functioning as reported by the patients themselves, which became small when only the most rigorous studies were considered.

If you already take medication for ADHD, do not stop it or adjust the dose on your own: any change should be discussed with your doctor. And taking stimulants without a prescription to perform better is not the same as treating ADHD: there is little evidence that it improves academic performance in people without ADHD (it has been studied mostly in university students), and in some people it has serious medical effects, even fatal ones.

Is it ADHD or is it the job?

Not every difficulty concentrating at work is ADHD. Ongoing stress, burnout, poor sleep, anxiety, depression, alcohol or other substance use, or bipolar disorder can look very similar, and at the same time ADHD often occurs together with mood, anxiety and substance use disorders. Telling them apart is precisely the job of an evaluation. On the adult ADHD page I explain how it differs from burnout.

You have probably come across an online test or social media videos describing ADHD. The WHO has a 6-question questionnaire for adults (ASRS), updated in 2017 to current criteria. It is useful for detecting possible cases, but a positive result is not a diagnosis: it means a full clinical evaluation is worthwhile. In the US general population sample in which that version was developed, about one in three people who screened positive did not have ADHD when evaluated; in a specialist clinic, positive results were confirmed more often. And although it was also designed for use at work, it has not been validated in workplace samples.

In the 2001-2003 surveys, very few adults with ADHD were receiving treatment for ADHD: in the US part, only 10.9% had received it in the past year. These data are more than 20 years old and do not say how things are today, or in Peru. What I do see in my practice are people treated for years for anxiety or depression whom nobody had asked about ADHD.

When to seek an evaluation?

An evaluation is worthwhile, to see whether it is ADHD or what else explains what is happening to you, if these difficulties go back a long way, to school or earlier, and don’t only appear in this job, and in addition:

  • You have spent years compensating with extra effort (late nights, lists, last-minute deliveries) and the tiredness is no longer sustainable.
  • You have been told, or you feel, that your performance doesn’t reflect your ability.
  • You are being treated for anxiety or depression and the forgetfulness, procrastination or disorganization are still there.
  • You change jobs or projects frequently without quite understanding why.
  • Someone in your family has an ADHD diagnosis and you recognize yourself in what they describe.

The evaluation looks at how you function today and how you functioned as a child, and looks for other causes that could explain the same thing, or that may be present alongside ADHD. I see patients in Spanish and in English.

Book an evaluation on WhatsApp

Frequently asked questions

Can I have ADHD if I'm doing well at work?
Yes, if the difficulties go back to childhood and also affect other areas of your life or cost you a lot of effort. In a US survey, most adults with ADHD were working, and the European consensus warns that high-functioning adults can compensate and not show the typical pattern of difficulties.

Is ADHD a superpower for entrepreneurship?
It is not proven. In a study of Swedish twins, hyperactivity symptoms were associated with self-employment, but the study did not measure whether those businesses did better, and ADHD symptoms were also associated with being unemployed.

Will medication make me perform better at work?
Some medications reduce ADHD symptoms in the short term in adults, but how much of that translates to work is poorly measured. Treatment usually has several parts, and any decision is made with your doctor. Taking stimulants without a prescription to perform better is not treating ADHD: there is little evidence that it helps you perform better, and it carries risks.

Can an online test tell me whether I have ADHD?
No. The WHO adult questionnaire is useful for detecting possible cases, but in the US general population sample in which its current version was developed, about one in three people who screened positive did not have ADHD. Diagnosis requires a clinical evaluation.

Could it be burnout and not ADHD?
Yes, and they can also coexist. Burnout is usually linked to a particular period or a specific job; ADHD is a pattern that goes back to childhood and appears in more than one area of life. Telling them apart is part of the evaluation.

Should I tell my boss that I have ADHD?
Studies do not give a single answer, and it depends a lot on each job and each person. It is a personal decision worth discussing in a consultation, and what is discussed there is protected by medical confidentiality.

This article is for information only and does not replace an individual medical evaluation or create a doctor-patient relationship. No treatment should be started, changed or stopped without discussing it with your doctor.

References

  1. de Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occupational and Environmental Medicine. 2008;65(12):835-842. doi:10.1136/oem.2007.038448
  2. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry. 2006;163(4):716-723. doi:10.1176/ajp.2006.163.4.716
  3. Adler LA, Faraone SV, Spencer TJ, Berglund P, Alperin S, Kessler RC. The structure of adult ADHD. International Journal of Methods in Psychiatric Research. 2017;26(1):e1555. doi:10.1002/mpr.1555
  4. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry. 2019;56:14-34. doi:10.1016/j.eurpsy.2018.11.001
  5. Verheul I, Rietdijk W, Block J, Franken I, Larsson H, Thurik R. The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employment. European Journal of Epidemiology. 2016;31(8):793-801. doi:10.1007/s10654-016-0159-1
  6. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021;128:789-818. doi:10.1016/j.neubiorev.2021.01.022
  7. Lauder K, McDowall A, Tenenbaum HR. A systematic review of interventions to support adults with ADHD at work: implications from the paucity of context-specific research for theory and practice. Frontiers in Psychology. 2022;13:893469. doi:10.3389/fpsyg.2022.893469
  8. Helgesson M, Björkenstam E, Rahman S, et al. Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal cohort study in Sweden. Psychological Medicine. 2023;53(4):1224-1232. doi:10.1017/S0033291721002701
  9. Taipale H, Bergström J, Gémes K, et al. Attention-deficit/hyperactivity disorder medications and work disability and mental health outcomes. JAMA Network Open. 2024;7(3):e242859. doi:10.1001/jamanetworkopen.2024.2859
  10. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NG87). 2018, updated 2019.
  11. Ustun B, Adler LA, Rudin C, et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry. 2017;74(5):520-527. doi:10.1001/jamapsychiatry.2017.0298
  12. Ostinelli EG, Schulze M, Zangani C, et al. Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry. 2025;12(1):32-43. doi:10.1016/S2215-0366(24)00360-2

Note on conflicts of interest: the preparation of study 1 was supported in part by an educational grant from Eli Lilly, and several of the national surveys it draws on had funding from pharmaceutical companies. In study 2, the validation interviews were supported by Eli Lilly and one of the authors worked at that company. The screening questionnaires used or evaluated in studies 3 and 11 were developed with support from Eli Lilly (and, the version in study 11, from Shire). Several authors of studies 3, 4, 6, 9, 11 and 12 declare payments or support from manufacturers of ADHD medication or other psychiatric drugs (in study 9, for work unrelated to that study). Studies 5, 7 and 8 declare no conflicts of interest; studies 8 and 9 were funded by a Swedish insurer, and study 7 by the Wellcome Trust.